Cabot Corp (CBT) Receives Average Rating of “Buy” from Brokerages

Cabot Corp (NYSE:CBT) has been assigned an average rating of “Buy” from the ten analysts that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $72.33.

Several equities analysts have recently issued reports on the company. Zacks Investment Research upgraded Cabot from a “hold” rating to a “buy” rating and set a $75.00 price target on the stock in a research report on Wednesday, January 17th. SunTrust Banks upgraded Cabot to a “buy” rating and set a $73.00 price target on the stock in a research report on Tuesday, January 16th. Loop Capital upgraded Cabot from a “hold” rating to a “buy” rating and set a $82.00 price target on the stock in a research report on Friday, January 5th. Northcoast Research set a $75.00 price target on Cabot and gave the company a “buy” rating in a research report on Monday. Finally, ValuEngine upgraded Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st.

Shares of Cabot (NYSE CBT) traded up $0.27 during trading on Tuesday, reaching $63.47. The company’s stock had a trading volume of 248,043 shares, compared to its average volume of 482,256. The company has a quick ratio of 1.02, a current ratio of 1.63 and a debt-to-equity ratio of 0.43. The company has a market cap of $3,841.31, a P/E ratio of 64.58, a P/E/G ratio of 1.55 and a beta of 1.25. Cabot has a 52-week low of $50.21 and a 52-week high of $68.63.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Tuesday, February 6th. The specialty chemicals company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.15. Cabot had a return on equity of 15.01% and a net margin of 2.30%. The company had revenue of $720.00 million for the quarter, compared to analysts’ expectations of $653.54 million. During the same period last year, the firm earned $0.84 EPS. The firm’s revenue for the quarter was up 17.8% on a year-over-year basis. equities research analysts predict that Cabot will post 4.02 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, March 9th. Investors of record on Friday, February 23rd will be issued a $0.315 dividend. This represents a $1.26 dividend on an annualized basis and a dividend yield of 1.99%. The ex-dividend date of this dividend is Thursday, February 22nd. Cabot’s payout ratio is 128.57%.

Several hedge funds and other institutional investors have recently modified their holdings of CBT. OxFORD Asset Management LLP grew its holdings in shares of Cabot by 131.9% in the 2nd quarter. OxFORD Asset Management LLP now owns 7,940 shares of the specialty chemicals company’s stock worth $424,000 after acquiring an additional 4,516 shares during the last quarter. Stifel Financial Corp acquired a new position in shares of Cabot in the 2nd quarter worth $302,000. HighTower Advisors LLC acquired a new position in shares of Cabot in the 2nd quarter worth $375,000. Royal Bank of Canada grew its holdings in shares of Cabot by 201.5% in the 2nd quarter. Royal Bank of Canada now owns 36,393 shares of the specialty chemicals company’s stock worth $1,945,000 after acquiring an additional 24,324 shares during the last quarter. Finally, Shelton Capital Management acquired a new position in shares of Cabot in the 2nd quarter worth $249,000. Institutional investors and hedge funds own 82.36% of the company’s stock.

WARNING: This piece was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.americanbankingnews.com/2018/02/13/cabot-corp-cbt-receives-average-rating-of-buy-from-brokerages.html.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply